• admin@ataxiatelangiectasia.es
Ataxia Telangiectasia
  • Home
  • Bibliography
    • Authors
    • Cells and molecules
    • Clinical
    • Country
    • Diseases
    • Drugs
    • Experimental
    • Journals
    • Methods
    • Year
  • Resources
  • What is A-T?
  • News

Bibliography

  • Comparison of major lymphocyte subpopulations and recent thymic emigrants in patients with ataxia telangiectasia and age-matched healthy groups.
    Hits: 913
    • ataxia telangiectasia
    • primary immunodeficiency
    • Turkey
    • Allergol Immunopathol (Madr)
    • Celiksoy MH
    • 2015
    • Topal E
    • Yıldıran A
    • CD31
    • Lymphocyte subpopulation
    • PECAM-1
    • Recent thymic emigrants
    Allergol Immunopathol (Madr). 2015 Sep-Oct;43(5):477-81. doi: 10.1016/j.aller.2014.06.007. Epub 2014 Nov 8.
    Celiksoy MH1, Topal E2, Yıldıran A3.

    Author information

    1
    Ondokuz Mayıs University, Medical Faculty, Department of Pediatric Allergy and Immunology, Samsun, Turkey. Electronic address: drmhc@hotmail.com.
    2
    Inonu University, Medical Faculty, Department of Pediatric Allergy and Immunology, Malatya, Turkey.
    3
    Ondokuz Mayıs University, Medical Faculty, Department of Pediatric Allergy and Immunology, Samsun, Turkey.

    Abstract

    BACKGROUND:

    Ataxia telangiectasia (A-T) is a genetic disorder caused by the homozygous mutation of the A-T mutated gene. It is frequently associated with variable degrees of cellular and humoral immunodeficiency. However, the immune defects in A-T patients are not well characterized. To the best of our knowledge, no studies have focused on the major lymphocyte subpopulations and recent thymic emigrants of A-T patients in comparison with age-matched healthy controls.

    METHODS:

    Following the European Society for Immunodeficiencies criteria, 17 patients diagnosed with A-The, and 12 age-matched healthy children were assigned to the study. Both patients and healthy controls were grouped as 1-5, 6-10, 11-15, and 15+ years. By using a flow cytometer, major lymphocyte subpopulations and CD4+CD45RA+CD31+ recent thymic emigrants were determined as percentage and absolute cell numbers and compared.

    RESULTS:

    No significant differences in all lymphocyte subpopulations were observed between the age groups of A-T patients. Compared to the healthy controls, there was a decrease in T cells, effector memory T4 cells, B cells, naïve B cells, naïve T4 cells, switched B cells, and recent thymic emigrants and an increase in active T8 cells and non-switched B cells in the percentage and absolute number of some cell populations in the A-T group.

    CONCLUSIONS:

    This study showed that effector functions in some cell lymphocyte populations were decreased in A-T patients.

    Copyright © 2014 SEICAP. Published by Elsevier Espana. All rights reserved.

    KEYWORDS:

    Ataxia–telangiectasia; CD31; Immunodeficiency; Lymphocyte subpopulation; PECAM-1; Recent thymic emigrants

    PMID:
     
    25456532
     
    DOI:
     
    10.1016/j.aller.2014.06.007
    [Indexed for MEDLINE]
  • Altered corticomotor-cerebellar integrity in young ataxia telangiectasia patients.
    Hits: 909
    • ataxia telangiectasia
    • Mov Disord
    • 2014
    • Sinclair K
    • Lavin MF
    • Australia
    • Sahama I
    • Fiori S
    • Pannek K
    • Rose S
    • Diffusion magnetic resonance imaging
    • Cerebellum
    • tract-based spatial statistics
    • voxel-based morphometry
    Mov Disord. 2014 Sep;29(10):1289-98. doi: 10.1002/mds.25970. Epub 2014 Jul 17.
    Sahama I1, Sinclair K, Fiori S, Pannek K, Lavin M, Rose S.

    Author information

    1
    The University of Queensland, School of Medicine, Brisbane, Australia.

    Abstract

    Magnetic resonance imaging (MRI) research in identifying altered brain structure and function in ataxia-telangiectasia, an autosomal recessive neurodegenerative disorder, is limited. Diffusion-weighted MRI were obtained from 11 ataxia telangiectasia patients (age range, 7-22 years; mean, 12 years) and 11 typically developing age-matched participants (age range, 8-23 years; mean, 13 years). Gray matter volume alterations in patients were compared with those of healthy controls using voxel-based morphometry, whereas tract-based spatial statistics was employed to elucidate white matter microstructure differences between groups. White matter microstructure was probed using quantitative fractional anisotropy and mean diffusivity measures. Reduced gray matter volume in both cerebellar hemispheres and in the precentral-postcentral gyrus in the left cerebral hemisphere was observed in ataxia telangiectasia patients compared with controls (P < 0.05, corrected for multiple comparisons). A significant reduction in fractional anisotropy in the cerebellar hemispheres, anterior/posterior horns of the medulla, cerebral peduncles, and internal capsule white matter, particularly in the left posterior limb of the internal capsule and corona radiata in the left cerebral hemisphere, was observed in patients compared with controls (P < 0.05). Mean diffusivity differences were observed within the left cerebellar hemisphere and the white matter of the superior lobule of the right cerebellar hemisphere (P < 0.05). Cerebellum-localized gray matter changes are seen in young ataxia telangiectasia patients along with white matter tract degeneration projecting from the cerebellum into corticomotor regions. The lack of cortical involvement may reflect early-stage white matter motor pathway degeneration within young patients.

    KEYWORDS:

    ataxia telangiectasia; cerebellum; diffusion magnetic resonance imaging; tract-based spatial statistics; voxel-based morphometry

    PMID:
     
    25042086
     
    DOI:
     
    10.1002/mds.25970
    [Indexed for MEDLINE]
  • DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors.
    Hits: 991
    • United States of America
    • Phenotype
    • 2014
    • neurology
    • risk factor
    • DNA repair
    • Neurogenetics
    • Gilmore EC
    Neurogenetics. 2014 Oct;15(4):217-28. doi: 10.1007/s10048-014-0415-z. Epub 2014 Jul 20.
    Gilmore EC1.

    Author information

    1
    Division of Child Neurology, Department of Pediatrics, Case Western Reserve University-Rainbow Babies and Children's Hospital-University Hospitals, Cleveland, OH, 44106, USA, ecg3@case.edu.

    Abstract

    Since identification of mutations in the ATM gene leading to ataxia-telangiectasia, enormous efforts have been devoted to discovering the roles this protein plays in DNA repair as well as other cellular functions. Even before the identification of ATM mutations, it was clear that other diseases with different genomic loci had very similar neurological symptoms. There has been significant progress in understanding why cancer and immunodeficiency occur in ataxia-telangiectasia even though many details remain to be determined, but the field is no closer to determining why the nervous system requires ATM and other DNA repair genes. Even though rodent disease models have similar DNA repair abnormalities as the human diseases, they have no consistent, robust neuropathological phenotype making it difficult to understand the neurological underpinnings of disease. Therefore, it may be useful to reassess the neurological and neuropathological characteristics of ataxia-telangiectasia in human patients to look for potential commonalities in DNA repair diseases that result in ataxia. In doing so, it is clear that ataxia-telangiectasia and similar diseases share neurological features other than merely ataxia, such as length-dependent motor and sensory neuropathies, and that the neuroanatomical localization for these symptoms is understood. Cells affected in ataxia-telangiectasiaand similar diseases are some of the largest single nucleated cells in the body. In addition, a subset of these diseases also has extrapyramidal movements and oculomotor apraxia. These neurological and neuropathological similarities may indicate a common DNA repair related pathogenesis with very large cell size as a critical risk factor.

    PMID:
     
    25038946
     
    DOI:
     
    10.1007/s10048-014-0415-z
    [Indexed for MEDLINE]
  • Cognitive phenotype in ataxia-telangiectasia.
    Hits: 1044
    • ataxia telangiectasia
    • Germany
    • United States of America
    • 2014
    • Kieslich M
    • cerebellum
    • Hoche F
    • Porto L
    • Pediatr Neurol
    • Schmahmann JD
    • Frankenberg E
    • Rambow J
    • Theis M
    • Harding JA
    • Qirshi M
    • Seidel K
    • Barbosa-Sicard E
    • basal ganglia
    • cerebellar cognitive affective syndrome
    • cognition
    • cognitive development
    • striatum
    Pediatr Neurol. 2014 Sep;51(3):297-310. doi: 10.1016/j.pediatrneurol.2014.04.027. Epub 2014 May 5.
    Hoche F1, Frankenberg E2, Rambow J2, Theis M2, Harding JA3, Qirshi M2, Seidel K4, Barbosa-Sicard E2, Porto L5, Schmahmann JD3, Kieslich M2.

    Author information

    1
    Cognitive Behavioral Neurology Unit, Ataxia Unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Neuropediatrics, Children's Hospital, Goethe-University, Frankfurt am Main, Germany. Electronic address: fhoche@mgh.harvard.edu.
    2
    Department of Neuropediatrics, Children's Hospital, Goethe-University, Frankfurt am Main, Germany.
    3
    Cognitive Behavioral Neurology Unit, Ataxia Unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
    4
    Dr. Senckenberg Chronomedical Institute, Goethe-University, Frankfurt am Main, Germany.
    5
    Department of Pediatric Neurology, Children's Hospital, Goethe-University Frankfurt am Main, Germany.

    Abstract

    BACKGROUND:

    Pediatric cerebrocerebellar neurodegenerative disorders such as ataxia-telangiectasia (AT) have not been examined in detail for neuropsychologic changes. Such studies may contribute to the further understanding of ataxia-telangiectasia and to the role of the cerebrocerebellar system in the development of cognitive function in childhood.

    METHODS:

    Twenty-two patients with the classic phenotype of ataxia-telangiectasia were grouped into early stage cerebellar disease (group AT-I) versus late stage cerebrocerebellar disease (group AT-II) and examined for neurocognitive features. Results were compared with those of healthy control subjects and with standard norms.

    RESULTS:

    Patients in AT-I group scored low average compared with standard norms on all tests and were impaired compared with healthy control subjects for verbal intelligence quotient (P < 0.001), vocabulary and comprehension (P = 0.007), processing speed (P = 0.005), visuospatial processing (P = 0.020), and working memory (P = 0.046). Patients in AT-II group scored below average compared with standard norms on all tests and were impaired compared with control subjects for attention (P < 0.001), working memory (P < 0.001), and abstract reasoning (P < 0.001). Comprehension scores were lower for patients in AT-II than in AT-I group (P = 0.002), whereas vocabulary scores showed no difference between groups (P = 0.480).

    CONCLUSION:

    Cognitive impairments in ataxia-telangiectasia present early, coinciding with cerebellar pathology and are characteristic of the cerebellar cognitive affective syndrome. Widespread and deeper cognitive deficits manifest in later stages of ataxia-telangiectasia when additional noncerebellar pathology develops. These results are the first indications of distinct cerebellar and extracerebellar and/or subcortical contributions to the range of cognitive domains affected in ataxia-telangiectasia and need to be confirmed in future studies.

    Copyright © 2014 Elsevier Inc. All rights reserved.

    KEYWORDS:

    ATM; ataxia-telangiectasia; basal ganglia; cerebellar cognitive affective syndrome; cerebellum; cognition; cognitive development; striatum

    PMID:
     
    25037873
     
    DOI:
     
    10.1016/j.pediatrneurol.2014.04.027
    [Indexed for MEDLINE]
  • Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia.
    Hits: 999
    • Israel
    • Nissenkorn A
    • Somech R
    • B cells
    • 2014
    • J Clin Immunol
    • Efrati O
    • Berkun Y
    • immunodeficiency
    • Kraus M
    • Lev A
    • Simon AJ
    • Levran I
    • Levi YB
    • Amariglio N
    • Rechavi G
    • T Cells
    J Clin Immunol. 2014 Jul;34(5):561-72. doi: 10.1007/s10875-014-0044-1. Epub 2014 May 1.
    Kraus M1, Lev A, Simon AJ, Levran I, Nissenkorn A, Levi YB, Berkun Y, Efrati O, Amariglio N, Rechavi G, Somech R.

    Author information

    1
    Pediatric Immunology Unit, Jeffrey Modell Foundation (JMF) Center and Department of Pediatrics, Sheba Medical Center, Tel Hashomer, Israel.

    Abstract

    OBJECTIVE:

    Ataxia telangiectasia (AT) is a rare genetic, multi-system disorder characterized by neurodegeneration, chromosome instability, B and T cell immunodeficiency and a predisposition to cancer. We examined immunologic parameters reflecting cell development and proliferation and their relevancy to the clinical phenotype in affected individuals.

    PATIENTS AND METHODS:

    AT patients from the AT National Clinic in Israel underwent immunological investigation. Their T and B cell workup included lymphocyte subset counts, immunoglobulin levels, responses to mitogenic stimulations, TCR-Vβ families and BCR immunoglobulin heavy chain spectratyping, TCR rearrangement excision circles (TRECs) and Kappa-deleting recombination excision circles (KRECs).

    RESULTS:

    Thirty-seven AT patients (median age 12.7 years, range 4.2-25.1) were evaluated. CD20 B and CD3 T lymphocytes were decreased in 67 % and 64 % of the patients, respectively, while only 33 % of the patients had reduced lymphoproliferative responses. Almost all AT patients displayed extremely low TRECs and KRECs levels, irrespective of their age. Those levels were correlated to one another and to the amounts of CD3+ and CD20+ cells, respectively. Abnormal TCR-Vβ repertoires were found with different degrees of clonality or reduced expression in these AT patients. There was no clear clustering of expansions to specific TCR-Vβ genes. PCR spectratyping analysis of the FR2 IgH BCR gene rearrangements in peripheral blood was abnormal in 50 % of the patients.

    CONCLUSION:

    The immunodeficiency associated with AT is combined, remains low over time and not progressive. It is characterized by low TREC and KREC copies suggestive of abnormal T and B cell neogenesis.

    PMID:
     
    24789685
     
    DOI:
     
    10.1007/s10875-014-0044-1
    [Indexed for MEDLINE]
  • Hypergonadotropic hypogonadism and hypersegmented neutrophils in a patient with ataxia-telangiectasia-like disorder: potential diagnostic clues?
    Hits: 970
    • 2014
    • Ataxia-Telangiectasia-Like Disorder
    • case
    • MRE11A gene
    • Am J Med Genet A
    • Yoshida T
    • Awaya T
    • Shibata M
    • Kato T
    • Numabe H
    • Kobayashi J
    • Komatsu K
    • Heike T
    • hypergonadotropic hypogonadism
    • hypersegmented neutrophil
    Am J Med Genet A. 2014 Jul;164A(7):1830-4. doi: 10.1002/ajmg.a.36546. Epub 2014 Apr 14.
    Yoshida T1, Awaya T, Shibata M, Kato T, Numabe H, Kobayashi J, Komatsu K, Heike T.

    Author information

    1
    Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.

    Abstract

    Ataxia-telangiectasia-like disorder (ATLD) is a rare autosomal recessive disorder, and has symptoms similar to ataxia-telangiectasia (AT). ATLD is caused by mutations in the MRE11 gene, involved in DNA double-strand break repair (DSBR). In contrast to AT, ATLD patients lack key clinical features, such as telangiectasia or immunodeficiency, and are therefore difficult to be diagnosed. We report a female ATLD patient presenting with hypergonadotropic hypogonadism and hypersegmented neutrophils, previously undescribed features in this disorder, and potential diagnostic clues to differentiate ATLD from other conditions. The patient showed slowly progressive cerebellar ataxia from 2 years of age, and MRI revealed atrophy of the cerebellum, oculomotor apraxia, mild cognitive impairment, writing dystonia, hypergonadotropic hypogonadism with primary amenorrhea, and hypersegmented neutrophils. Western blot assay demonstrated total loss of MRE11 and reduction of ATM-dependent phosphorylation; thus, we diagnosed ATLD. Genetically, a novel missense mutation (c.140C>T) was detected in the MRE11 gene, but no other mutation was found in the patient. Our presenting patient suggests that impaired DSBR may be associated with hypergonadotropic hypogonadism and neutrophil hypersegmentation. In conclusion, when assessing patients with ataxia of unknown cause, ATLD should be considered, and the gonadal state and peripheral blood smear samples evaluated.

    KEYWORDS:

    ATLD; MRE11; ataxia-telangiectasia-like disorder; hypergonadotropic hypogonadism; hypersegmented neutrophil

    PMID:
     
    24733832
     
    DOI:
     
    10.1002/ajmg.a.36546
    [Indexed for MEDLINE] 
    Free full text
  • Radiological imaging in ataxia telangiectasia: a review.
    Hits: 1017
    • Sinclair K
    • Lavin MF
    • Australia
    • Magnetic resonance imaging
    • Sahama I
    • Pannek K
    • Rose S
    • Cerebellum

    Cerebellum. 2014 Aug;13(4):521-30. doi: 10.1007/s12311-014-0557-4.

    Sahama I1, Sinclair K, Pannek K, Lavin M, Rose S.

    Author information

    1
    School of Medicine, The University of Queensland, Brisbane, Australia.

    Abstract

    The human genetic disorder ataxia telangiectasia (A-T) is characterised by neurodegeneration, immunodeficiency, radiosensitivity, cell cycle checkpoint defects, genomic instability and cancer predisposition. Progressive cerebellar ataxia represents the most debilitating aspect of this disorder. At present, there is no therapy available to cure or prevent the progressive symptoms of A-T. While it is possible to alleviate some of the symptoms associated with immunodeficiency and deficient lung function, neither the predisposition to cancer nor the progressive neurodegeneration can be prevented. Significant effort has focused on improving our understanding of various clinical, genetic and immunological aspects of A-T; however, little attention has been directed towards identifying altered brain structure and function using MRI. To date, most imaging studies have reported radiological anomalies in A-T. This review outlines the clinical and biological features of A-T along with known radiological imaging anomalies. In addition, we briefly discuss the advent of high-resolution MRI in conjunction with diffusion-weighted imaging, which enables improved investigation of the microstructural tissue environment, giving insight into the loss in integrity of motor networks due to abnormal neurodevelopmental or progressive neurodegenerative processes. Such imaging approaches have yet to be applied in the study of A-T and could provide important new information regarding the relationship between mutation of the ataxia telangiectasia mutated (ATM) gene and the integrity of motor circuitry.

    PMID:
     
    24683014
     
    DOI:
     
    10.1007/s12311-014-0557-4
    [Indexed for MEDLINE]
  • Whole-exome sequence analysis of ataxia telangiectasia-like phenotype.
    Hits: 975
    • Japan
    • CD40L
    • 2014
    • Neurodegeneration
    • immunodeficiency
    • J Neurol Sci
    • DNA damage response
    • SIL1
    • Whole-exome sequencing
    J Neurol Sci. 2014 May 15;340(1-2):86-90. doi: 10.1016/j.jns.2014.02.033. Epub 2014 Mar 4.
    Hasegawa S1, Imai K1, Yoshida K2, Okuno Y3, Muramatsu H4, Shiraishi Y5, Chiba K5, Tanaka H6, Miyano S6, Kojima S4, Ogawa S2, Morio T1, Mizutani S1, Takagi M7.

    Author information

    1
    Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.
    2
    Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
    3
    Cancer Genomics Project, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
    4
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
    5
    Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
    6
    Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
    7
    Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: m.takagi.ped@tmd.ac.jp.

    Abstract

    A number of diseases exhibit neurodegeneration with/without additional symptoms such as immunodeficiency, increased cancer risk, and microcephalus. Ataxia telangiectasia and Nijmegen breakage syndrome, for example, develop as a result of mutations in genes involved in the DNA damage response. However, such diseases can be difficult to diagnose as they are only rarely encountered by physicians. To overcome this challenge, nine patients with symptoms that resemble those of ataxia telangiectasia, including neurodegeneration, hypogammaglobulinemia, telangiectasia, and/or elevated serum α-fetoprotein, were subjected to whole-exome sequencing (WES) to identify the causative mutations. Molecular diagnosis was achieved in two patients: one displayed CD40 ligand (CD40LG) deficiency, while a second showed a homozygous SIL1 mutation, which has been linked to Marinesco-Sjögren syndrome (MSS). Typical features of CD40LG deficiency and MSS are distinct from the symptoms usually seen in ataxia telangiectasia. These dissociations between phenotype and genotype make it difficult to achieve molecular diagnosis of orphan diseases. Whole-exome sequencing analyses will assist in the molecular diagnosis of such cases and allow the identification of genotypes that would not be expected from the phenotype.

    KEYWORDS:

    CD40 ligand; DNA damage; Immunodeficiency; Neurodegeneration; SIL1; Whole-exome sequencing

    PMID:
     
    24631270
     
    DOI:
     
    10.1016/j.jns.2014.02.033
    [Indexed for MEDLINE]
  • Microbiological surveillance in lung disease in ataxia telangiectasia.
    Hits: 1006
    • ataxia telangiectasia
    • United Kingdom
    • 2014
    • Bush A
    • Bhatt JM
    • Eur Respir J
    • microbiological surveillance
    • lung disease
    Eur Respir J. 2014 Jun;43(6):1797-801. doi: 10.1183/09031936.00141413. Epub 2014 Feb 13.
    Bhatt JM1, Bush A2.

    Author information

    1
    National Paediatric Ataxia Telangiectasia Clinic, Nottingham jayesh.bhatt@nuh.nhs.uk.
    2
    Imperial College and Royal Brompton Harefield NHS Foundation Trust, London, UK.
    PMID:
     
    24525444
     
    DOI:
     
    10.1183/09031936.00141413
    [Indexed for MEDLINE] 
    Free full text
  • Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.
    Hits: 933
    • United Kingdom
    • Phenotype
    • 2014
    • Taylor AMR
    • Haematologica
    • Agathanggelou A
    • Weston VJ
    • Perry T
    • Davies NJ
    • Skowronska A
    • Payne DT
    • Fossey JS
    • Oldreive CE
    • Wei W
    • Pratt G
    • Parry H
    • Oscier D
    • Coles SJ
    • Hole PS
    • Darley RL
    • McMahon M
    • Hayes JD
    • Moss P
    • Stewart GS
    • Stankovic T
    • chronic lymphocytic leukemia
    • pro-oxidants
    Haematologica. 2015 Aug;100(8):1076-85. doi: 10.3324/haematol.2014.115170. Epub 2015 Apr 3.
    Agathanggelou A1, Weston VJ1, Perry T1, Davies NJ1, Skowronska A1, Payne DT2, Fossey JS2, Oldreive CE1, Wei W1, Pratt G3, Parry H4, Oscier D5, Coles SJ6, Hole PS6, Darley RL6, McMahon M7, Hayes JD7, Moss P1, Stewart GS1, Taylor AM1, Stankovic T8.

    Author information

    1
    School of Cancer Sciences, University of Birmingham.
    2
    School of Chemistry, University of Birmingham.
    3
    School of Cancer Sciences, University of Birmingham Haematology Department, Birmingham Heartlands Hospital.
    4
    Haematology Department, Birmingham Heartlands Hospital.
    5
    Haematology Department, Royal Bournemouth Hospital, Dorset.
    6
    Department of Haematology, Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff.
    7
    Medical Research Institute, University of Dundee, UK.
    8
    School of Cancer Sciences, University of Birmingham t.stankovic@bham.ac.uk.

    Abstract

    Inactivation of the Ataxia Telangiectasia Mutated gene in chronic lymphocytic leukemia results in resistance to p53-dependent apoptosis and inferior responses to treatment with DNA damaging agents. Hence, p53-independent strategies are required to target Ataxia TelangiectasiaMutated-deficient chronic lymphocytic leukemia. As Ataxia Telangiectasia Mutated has been implicated in redox homeostasis, we investigated the effect of the Ataxia Telangiectasia Mutated-null chronic lymphocytic leukemia genotype on cellular responses to oxidative stress with a view to therapeutic targeting. We found that in comparison to Ataxia Telangiectasia Mutated-wild type chronic lymphocytic leukemia, pro-oxidant treatment of Ataxia Telangiectasia Mutated-null cells led to reduced binding of NF-E2 p45-related factor-2 to antioxidant response elements and thus decreased expression of target genes. Furthermore, Ataxia Telangiectasia Mutated-null chronic lymphocytic leukemia cells contained lower levels of antioxidants and elevated mitochondrial reactive oxygen species. Consequently, Ataxia Telangiectasia Mutated-null chronic lymphocytic leukemia, but not tumors with 11q deletion or TP53 mutations, exhibited differentially increased sensitivity to pro-oxidants both in vitro and in vivo. We found that cell death was mediated by a p53- and caspase-independent mechanism associated with apoptosis inducing factor activity. Together, these data suggest that defective redox-homeostasis represents an attractive therapeutic target for Ataxia Telangiectasia Mutated-null chronic lymphocytic leukemia.

    PMID:
     
    25840602
     
    PMCID:
     
    PMC5004424
     
    DOI:
     
    10.3324/haematol.2014.115170
    [Indexed for MEDLINE] 
    Free PMC Article
  • ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.
    Hits: 987
    • United Kingdom
    • ATM
    • 2012
    • Powell JE
    • Haematologica
    • Weston VJ
    • Skowronska A
    • Pratt G
    • Moss P
    • Stankovic T
    • chronic lymphocytic leukemia
    • Austen B
    • Oscier DG
    • Dyer MJ
    • Matutes E
    • Fegan C
    • Taylor MA
    Haematologica. 2012 Jan;97(1):142-6. doi: 10.3324/haematol.2011.048827. Epub 2011 Sep 20.
    Skowronska A1, Austen B, Powell JE, Weston V, Oscier DG, Dyer MJ, Matutes E, Pratt G, Fegan C, Moss P, Taylor MA, Stankovic T.

    Author information

    1
    School of Cancer Sciences, University of Birmingham, University of Birmingham, Birmingham B15 2TT, UK. t.stankovic@bham.ac.uk

    Abstract

    Ataxia telangiectasia patients, with constitutional bi-allelic ATM mutations, have a marked risk of lymphoid tumors and ATM mutation carriers have a smaller risk of cancer. Sporadic ATM mutations occur in 10-20% of chronic lymphocytic leukemia and are often associated with chromosome 11q deletions which cause loss of an ATM allele. The role of constitutional ATM mutations in the pathogenesis of chronic lymphocytic leukemia is unknown. Here we investigated the frequency of constitutional ATM mutations in either of two chronic lymphocytic leukemia cohorts, those with and without a chromosome 11q deletion. We found that in comparison to controls, constitutional pathogenic ATM mutations were increased in patients with chromosome 11q deletions (6 of 140 vs. 0 of 281, P = 0.001) but not in those without 11q deletions (2 of 178 vs. 0 of 281, P = 0.15). These results suggest that ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but rather influences rapid disease progression through ATM loss.

    Comment in

    • ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter. [Haematologica. 2012]
    PMID:
     
    21933854
     
    PMCID:
     
    PMC3248944
     
    DOI:
     
    10.3324/haematol.2011.048827
    [Indexed for MEDLINE] 
    Free PMC Article
  • A germline chromothripsis event stably segregating in 11 individuals through three generations.
    Hits: 978
    • Germany
    • The Netherlands
    • 2016
    • Denmark
    • Genet Med
    • Bertelsen B
    • Nazaryan-Petersen L
    • Sun W
    • Mehrjouy MM
    • Xie G
    • Chen W
    • Hjermind LE
    • Taschner PE
    • Tümer Z
    • germline chromothripsis
    Genet Med. 2016 May;18(5):494-500. doi: 10.1038/gim.2015.112. Epub 2015 Aug 27.
    Bertelsen B1, Nazaryan-Petersen L1, Sun W2, Mehrjouy MM3, Xie G2, Chen W2, Hjermind LE4, Taschner PE5, Tümer Z1.

    Author information

    1
    Department of Clinical Genetics, Applied Human Molecular Genetics, Kennedy Center, Copenhagen University Hospital, Glostrup, Denmark.
    2
    Max Delbrück Center for Molecular Medicine, Berlin Institute for Medical Systems Biology, Berlin, Germany.
    3
    Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
    4
    Neurogenetics Clinic, Danish Dementia Research Centre, Department of Neurology, Rigshospitalet, and Department of Cellular and Molecular Medicine, Section of Neurogenetics, University of Copenhagen, Copenhagen, Denmark.
    5
    Generade Center of Expertise Genomics; University of Applied Sciences Leiden, Leiden, The Netherlands.

    Abstract

    PURPOSE:

    Parentally transmitted germ-line chromothripsis (G-CTH) has been identified in only a few cases. Most of these rearrangements were stably transmitted, in an unbalanced form, from a healthy mother to her child with congenital abnormalities probably caused by de novo copy-number changes of dosage sensitive genes. We describe a G-CTH transmitted through three generations in 11 healthy carriers.

    METHODS:

    Conventional cytogenetic analysis, mate-pair sequencing, and polymerase chain reaction (PCR) were used to identify the chromosome rearrangement and characterize the breakpoints in all three generations.

    RESULTS:

    We identified an apparently balanced translocation t(3;5), later shown to be a G-CTH, in all individuals of a three-generation family. The G-CTH stably segregated without occurrence of additional rearrangements; however, several spontaneous abortions were reported, possibly due to unbalanced transmission. Although seven protein-coding genes are interrupted, no clinical features can be definitively attributed to the affected genes. However, it can be speculated that truncation of one of these genes, encoding ataxia-telangiectasia and Rad3-related protein kinase (ATR), a key component of the DNA damage response, may be related to G-CTH formation.

    CONCLUSION:

    G-CTH rearrangements are not always associated with abnormal phenotypes and may be misinterpreted as balanced two-way translocations, suggesting that G-CTH is an underdiagnosed phenomenon.Genet Med 18 5, 494-500.

    PMID:
     
    26312826
     
    DOI:
     
    10.1038/gim.2015.112
    [Indexed for MEDLINE]
  • Germline Chromothripsis Driven by L1-Mediated Retrotransposition and Alu/Alu Homologous Recombination.
    Hits: 1008
    • Bertelsen B
    • Nazaryan-Petersen L
    • Tümer Z
    • germline chromothripsis
    • Hum Mutat
    • Bak M
    • Jønson L
    • Tommerup N
    • Hancks DC
    Hum Mutat. 2016 Apr;37(4):385-95. doi: 10.1002/humu.22953. Epub 2016 Feb 4.
    Nazaryan-Petersen L1,2, Bertelsen B1, Bak M3, Jønson L4, Tommerup N3, Hancks DC5, Tümer Z1.

    Author information

    1
    Applied Human Molecular Genetics, Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Glostrup, 2600, Denmark.
    2
    Department of Cellular and Molecular Medicine (ICMM), Faculty of Health Science, University of Copenhagen, Copenhagen, N. 2200, Denmark.
    3
    Department of Cellular and Molecular Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, N. 2200, Denmark.
    4
    Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, O. 2100, Denmark.
    5
    Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, 84112.

    Abstract

    Chromothripsis (CTH) is a phenomenon where multiple localized double-stranded DNA breaks result in complex genomic rearrangements. Although the DNA-repair mechanisms involved in CTH have been described, the mechanisms driving the localized "shattering" process remain unclear. High-throughput sequence analysis of a familial germline CTH revealed an inserted SVAE retrotransposon associated with a 110-kb deletion displaying hallmarks of L1-mediated retrotransposition. Our analysis suggests that the SVAE insertion did not occur prior to or after, but concurrent with the CTH event. We also observed L1-endonuclease potential target sites in other breakpoints. In addition, we found four Alu elements flanking the 110-kb deletion and associated with an inversion. We suggest that chromatin looping mediated by homologous Alu elements may have brought distal DNA regions into close proximity facilitating DNA cleavage by catalytically active L1-endonuclease. Our data provide the first evidence that active and inactive human retrotransposons can serve as endogenous mutagens driving CTH in the germline.

    KEYWORDS:

    Alu; L1; LINE-1; NAHR; SINE-VNTR-Alu; SVA; chromothripsis; nonallelic homologous recombination

    Comment in

    • A Mechanistic Link between L1 Retrotransposition and Chromothripsis. [Hum Mutat. 2016]
    PMID:
     
    26929209
     
    DOI:
     
    10.1002/humu.22953
    [Indexed for MEDLINE]
  • Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging.
    Hits: 959
    • ataxia telangiectasia
    • Italy
    • 2013
    • Pignata C
    • Pietrogrande MC
    • Pession A
    • J Clin Immunol
    • Finocchi A
    • lung disease
    • Montella S
    • Mollica C
    • Trizzino A
    • Ranucci G
    • Maglione M
    • Giardino G
    • Salvatore M
    • Santamaria F
    • high-field magnetic resonance imaging
    J Clin Immunol. 2013 Oct;33(7):1185-91. doi: 10.1007/s10875-013-9933-y. Epub 2013 Aug 24.
    Montella S1, Mollica C, Finocchi A, Pession A, Pietrogrande MC, Trizzino A, Ranucci G, Maglione M, Giardino G, Salvatore M, Santamaria F, Pignata C.

    Author information

    1
    Department of Translational Medical Sciences, "Federico II" University, Via Pansini 5, 80131, Naples, Italy.

    Abstract

    PURPOSE:

    A sensitive imaging technique that assesses ataxia telangiectasia (AT) lung disease without ionizing radiation is highly desirable. We designed a study to evaluate lung changes using magnetic resonance imaging (MRI), and to investigate the relationships among severity and extent of pulmonary abnormalities and clinical, microbiological and functional data in children and young adults with AT.

    METHODS:

    Fifteen AT patients (age, 11.3 years; range, 6-31) underwent 3.0-T MRI, spirometry, and deep throat or sputum culture. Images were scored using a modified Helbich score.

    RESULTS:

    Although only 8 patients (53 %) had recurrent/chronic respiratory symptoms, MRI identified lung abnormalities in all. Bronchiectasis, peribronchial thickening, mucous plugging, and collapse/consolidation were present in 60 %, 87 %, 67 %, and 13 % of cases, respectively, with no difference between subjects with or without respiratory symptoms. No difference in changes of specific scores was found between the two groups, but the total MRI score was higher in patients with respiratory symptoms (6.5 versus 5, respectively; p = 0.02). Total or specific MRI scores were not associated with patients' age. Of all scores, only mucous plugging subscore appeared significantly related to FEV1 (r = 0.7, p = 0.04) and FEF25-75% (r = 0.9, p = 0.001). MRI scores from patients with positive (n = 5) or negative (n = 10) sputum culture were not significantly different.

    CONCLUSIONS:

    MRI is valuable in the assessment of extent and severity of pulmonary changes in children and adults with AT. It represents an helpful tool for the longitudinal evaluation of patients and may be also used as an outcome surrogate to track the effects of medications.

    PMID:
     
    23975689
     
    DOI:
     
    10.1007/s10875-013-9933-y
    [Indexed for MEDLINE]
  • Senataxin controls meiotic silencing through ATR activation and chromatin remodeling.
    Hits: 1004
    • 2015
    • Australia
    • Yeo AJ
    • Becherel OJ
    • Luff JE
    • Graham ME
    • Richard D
    • Senataxin
    • ATR
    Cell Discov. 2015 Sep 29;1:15025. doi: 10.1038/celldisc.2015.25. eCollection 2015.

     controls meiotic silencing through ATR activation and chromatin remodeling.

    Yeo AJ1, Becherel OJ2, Luff JE3, Graham ME4, Richard D5, Lavin MF1.

    Author information

    1
    The University of Queensland, UQ Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia; School of Medicine, The University of Queensland, Herston, Brisbane, QLD, Australia.
    2
    The University of Queensland, UQ Centre for Clinical Research (UQCCR), Brisbane, QLD, Australia; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Brisbane, QLD, Australia.
    3
    The University of Queensland, UQ Centre for Clinical Research (UQCCR) , Brisbane, QLD, Australia.
    4
    Children's Medical Research Institute, The University of Sydney , Westmead, NSW, Australia.
    5
    Cancer and Ageing Research Program, Faculty of Health, Queensland University of Technology , Brisbane, QLD, Australia.

    Abstract

    Senataxin, defective in ataxia oculomotor apraxia type 2, protects the genome by facilitating the resolution of RNA-DNA hybrids (R-loops) and other aspects of RNA processing. Disruption of this gene in mice causes failure of meiotic recombination and defective meiotic sex chromosome inactivation, leading to male infertility. Here we provide evidence that the disruption of Setx leads to reduced SUMOylation and disruption of protein localization across the XY body during meiosis. We demonstrate that senataxin and other DNA damage repair proteins, including ataxia telangiectasia and Rad3-related protein-interacting partner, are SUMOylated, and a marked downregulation of both ataxia telangiectasia and Rad3-related protein-interacting partner and TopBP1 leading to defective activation and signaling through ataxia telangiectasia and Rad3-related protein occurs in the absence of senataxin. Furthermore, chromodomain helicase DNA-binding protein 4, a component of the nucleosome remodeling and deacetylase chromatin remodeler that interacts with both ataxia telangiectasia and Rad3-related protein and senataxin was not recruited efficiently to the XY body, triggering altered histone acetylation and chromatin conformation in Setx (-/-) pachytene-staged spermatocytes. These results demonstrate that senataxin has a critical role in ataxia telangiectasia and Rad3-related protein- and chromodomain helicase DNA-binding protein 4-mediated transcriptional silencing and chromatin remodeling during meiosis providing greater insight into its critical role in gene regulation to protect against neurodegeneration.

    KEYWORDS:

    DNA damage repair; chromatin remodeling; meiosis; senataxin; transcription

    PMID:
     
    27462424
     
    PMCID:
     
    PMC4860845
     
    DOI:
     
    10.1038/celldisc.2015.25
    Free PMC Article
     
  • Cerebral abnormalities in adults with ataxia-telangiectasia.
    Hits: 977
    • ataxia telangiectasia
    • United States of America
    • 2014
    • Lederman HM
    • Crawford TO
    • AJNR Am J Neuroradiol
    • Lin DD
    • Barker PB
    • cerebral abnormalities
    • adults
    AJNR Am J Neuroradiol. 2014 Jan;35(1):119-23. doi: 10.3174/ajnr.A3646. Epub 2013 Jul 25.

    Cerebral abnormalities in adults with ataxia-telangiectasia.

    Lin DD1, Barker PB, Lederman HM, Crawford TO.

    Author information

    1
    Departments of Radiology and Radiological Science.

    Abstract

    Ataxia-telangiectasia, an autosomal recessive disorder caused by defect of the ataxia-telangiectasia mutated gene, is characterized by progressive neurologic impairment with cerebellar atrophy, ocular and cutaneous telangiectasia, immunodeficiency, heightened sensitivity to ionizing radiation and susceptibility to developing lymphoreticular malignancy. Supratentorial brain abnormalities have been reported only rarely. In this study, brain MRI was performed in 10 adults with ataxia-telangiectasia having stable neurologic impairment. Intracerebral telangiectasia with multiple punctate hemosiderin deposits were identified in 60% of subjects. These lesions were apparently asymptomatic. They are similar in appearance to radiation-induced telangiectasia and to cryptogenic vascular malformations. Also noted, in the 2 oldest subjects, was extensive white matter T2 hyperintensity, and in 1 of these a space-occupying fluid collection consistent with transudative capillary leak and edema as evidenced by reduced levels of metabolites on MR spectroscopic imaging. Asymptomatic supratentorial vascular abnormalities appear to be common in adults with ataxia-telangiectasia.

    PMID:
     
    23886747
     
    PMCID:
     
    PMC4106125
     
    DOI:
     
    10.3174/ajnr.A3646
    [Indexed for MEDLINE] 
    Free PMC Article
     
  • Disorders of Upper Limb Movements in Ataxia-Telangiectasia.
    Hits: 1066
    • ataxia telangiectasia
    • United States of America
    • 2013
    • Lederman HM
    • cerebellum
    • PLoS One
    • Crawford TO
    • Shaikh AG
    • Zee DS
    • basal ganglia
    • Mandir AS
    • Disorders of Upper Limb Movements
    PLoS One. 2013 Jun 27;8(6):e67042. doi: 10.1371/journal.pone.0067042. Print 2013.
    Shaikh AG1, Zee DS, Mandir AS, Lederman HM, Crawford TO.

    Author information

    1
    Department of Neurology, Case Western Reserve University, Cleveland, Ohio, United States of America.

    Abstract

    Ataxia-telangiectasia is known for cerebellar degeneration, but clinical descriptions of abnormal tone, posture, and movements suggest involvement of the network between cerebellum and basal ganglia. We quantitatively assessed the nature of upper-limb movement disorders in ataxia-telangiectasia. We used a three-axis accelerometer to assess the natural history and severity of abnormal upper-limb movements in 80 ataxia-telangiectasia and 19 healthy subjects. Recordings were made during goal-directed movements of upper limb (kinetic task), while arms were outstretched (postural task), and at rest. Almost all ataxia-telangiectasia subjects (79/80) had abnormal involuntary movements, such as rhythmic oscillations (tremor), slow drifts (dystonia or athetosis), and isolated rapid movements (dystonic jerks or myoclonus). All patients with involuntary movements had both kinetic and postural tremor, while 48 (61%) also had resting tremor. The tremor was present in transient episodes lasting several seconds during two-minute recording sessions of all three conditions. Percent time during which episodic tremor was present was greater for postural and kinetic tasks compared to rest. Resting tremor had higher frequency but smaller amplitude than postural and kinetic tremor. Rapid non-rhythmic movements were minimal during rest, but were triggered during sustained arm postures and goal directed arm movements suggesting they are best considered a form of dystonic jerks or action myoclonus. Advancing age did not correlate with the severity of involuntary limb movements. Abnormal upper-limb movements in ataxia-telangiectasia feature classic cerebellar impairment, but also suggest involvement of the network between the cerebellum and basal ganglia.

    PMID:
     
    23826191
     
    PMCID:
     
    PMC3694953
     
    DOI:
     
    10.1371/journal.pone.0067042
    [Indexed for MEDLINE] 
    Free PMC Article
     
  • Pulmonary function in children and young adults with ataxia telangiectasia.
    Hits: 1016
    • ataxia telangiectasia
    • United States of America
    • Lung functions
    • 2014
    • McGrath-Morrow SA
    • Collaco JM
    • Lederman HM
    • Lefton-Greif MA
    • Crawford TO
    • Wright J
    • Pediatr Pulmonol
    • adults
    • Aherrera AD
    • Ryan T
    • youngs
    Pediatr Pulmonol. 2014 Jan;49(1):84-90. doi: 10.1002/ppul.22760. Epub 2013 Feb 8.
    McGrath-Morrow SA1, Lederman HM, Aherrera AD, Lefton-Greif MA, Crawford TO, Ryan T, Wright J, Collaco JM.

    Author information

    1
    Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.

    Abstract

    BACKGROUND:

    Pulmonary disease contributes to significant morbidity and mortality in people with ataxia telangiectasia (A-T). To determine the association between age and lung function in children and young adults with A-T and to identify factors associated with decreased lung function, pulmonary function tests were performed in 100 consecutive people with A-T.

    METHODS:

    Children and adults ranging from 6 to 29 years of age and with the diagnosis of A-T were recruited, and underwent pulmonary function tests.

    RESULTS:

    The mean forced vital capacity % predicted (FVC %) in the population was 56.6 ± 20.0. Males and females between 6 and 10 years of age had similar pulmonary function. Older females were found to have significantly lower FVCs % than both older males (P < 0.02) and younger females (P < 0.001). The use of supplemental gamma globulin was associated with significantly lower FVC %. A modest correlation was found between higher radiation-induced chromosomal breakage and lower FVC % in males. No significant change in FVC % was found in a subset of subjects (n = 25) who underwent pulmonary function testing on two or more occasions over an average of 2 years.

    CONCLUSION:

    In children and young adults with A-T, older females and people who required supplemental gamma globulin had significantly lower lung function by cross-sectional analysis. Stable lung function is possible over a 2-year period. Recognition of groups who are at higher risk for lower pulmonary function may help direct care and improve clinical outcomes in people with A-T.

    © 2013 Wiley Periodicals, Inc.

    KEYWORDS:

    ataxia telangiectasia; lung; pulmonary function

    PMID:
     
    23401357
     
    PMCID:
     
    PMC4423797
     
    DOI:
     
    10.1002/ppul.22760
    [Indexed for MEDLINE] 
    Free PMC Article
  • Anesthetic and perioperative risk in the patient with Ataxia-Telangiectasia.
    Hits: 1036
    • ataxia telangiectasia
    • United States of America
    • 2012
    • McGrath-Morrow SA
    • Lederman HM
    • Crawford TO
    • Lockman JL
    • Iskander AJ
    • Bembea M
    • Easley RB
    • Paediatr Anaesth
    • anesthesia
    • perioperative risk
    Paediatr Anaesth. 2012 Mar;22(3):256-62. doi: 10.1111/j.1460-9592.2011.03739.x. Epub 2011 Nov 21.
    Lockman JL1, Iskander AJ, Bembea M, Crawford TO, Lederman HM, McGrath-Morrow S, Easley RB.

    Author information

    1
    Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Hospital, Baltimore, MD, USA.

    Abstract

    OBJECTIVES/AIM:

    To report our relatively large experience with perioperative care for patients with Ataxia-Telangiectasia (A-T) and to identify the nature and frequency of complications.

    BACKGROUND:

    Ataxia-Telangiectasia is a rare autosomal recessive genetic disorder resulting in progressive multisystem degeneration and characteristic findings including complex neurodegeneration, immunodeficiency, increased risk of malignancy, and lung disease. Anecdotal reports have suggested high perioperative morbidity in patients with A-T, but few data exist.

    METHODS/MATERIALS:

    The Ataxia-Telangiectasia Clinical Center database was cross-referenced with operative records between 1995 and 2009 to identify patients with perioperative A-T, and medical records were reviewed for preoperative history, management techniques, and complications.

    RESULTS:

    Twenty-one patients with A-T underwent 34 anesthetics during the study period. The median age was 12.5 years (range 6-33 years). Common comorbidities included neurologic (100%), pulmonary (68%), immunologic (50%), oncologic (47%), and gastroenterologic (35%) disorders. Supplemental oxygen was required on postanesthesia care unit discharge for 24% of patients with a maximal duration of 24 h. Although mild postoperative hypothermia was relatively common (44% of anesthetics), there were no major complications, no unplanned admissions, and no mortality in this series.

    CONCLUSIONS:

    Although limited by its retrospective nature, this is the first series describing perioperative risk for patients with A-T. Our results indicate that general anesthesia, airway manipulation, and perioperative mechanical ventilation may be tolerated with only minor postoperative anesthetic concerns. Perioperative providers should be aware of the complex multisystem medical concerns that may arise in these patients.

    © 2011 Blackwell Publishing Ltd.

    PMID:
     
    22098343
     
    DOI:
     
    10.1111/j.1460-9592.2011.03739.x
    [Indexed for MEDLINE]
  • Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology.
    Hits: 1024
    • ataxia telangiectasia
    • United States of America
    • 2011
    • Lederman HM
    • Crawford TO
    • Rothblum-Oviatt C
    • Int J Proteomics
    • Dzieciatkowska M
    • Qi G
    • You J
    • Bemis KG
    • Sahm H
    • Gelbert LM
    • Wang M
    • Cerebrospinal Fluid
    • proteomic
    Int J Proteomics. 2011;2011:578903. doi: 10.1155/2011/578903. Epub 2011 Jun 23.
    Dzieciatkowska M1, Qi G, You J, Bemis KG, Sahm H, Lederman HM, Crawford TO, Gelbert LM, Rothblum-Oviatt C, Wang M.

    Author information

    1
    Department Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Dr., MS 4053, Indianapolis, IN 46202, USA.

    Abstract

    Cerebrospinal fluid (CSF) has been used for biomarker discovery of neurodegenerative diseases in humans since biological changes in the brain can be seen in this biofluid. Inactivation of A-T-mutated protein (ATM), a multifunctional protein kinase, is responsible for A-T, yet biochemical studies have not succeeded in conclusively identifying the molecular mechanism(s) underlying the neurodegeneration seen in A-T patients or the proteins that can be used as biomarkers for neurologic assessment of A-T or as potential therapeutic targets. In this study, we applied a high-throughput LC/MS-based label-free protein quantification technology to quantitatively characterize the proteins in CSF samples in order to identify differentially expressed proteins that can serve as potential biomarker candidates for A-T. Among 204 identified CSF proteins with high peptide-identification confidence, thirteen showed significant protein expression changes. Bioinformatic analysis revealed that these 13 proteins are either involved in neurodegenerative disorders or cancer. Future molecular and functional characterization of these proteins would provide more insights into the potential therapeutic targets for the treatment of A-T and the biomarkers that can be used to monitor or predict A-T disease progression. Clinical validation studies are required before any of these proteins can be developed into clinically useful biomarkers.

    PMID:
     
    22084690
     
    PMCID:
     
    PMC3200215
     
    DOI:
     
    10.1155/2011/578903
    Free PMC Article

Page 8 of 21

  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12

Language

Select your language

  • Hindi (India)
  • Hebrew
  • Arabic (اللغة العربية)
  • Turkish (Turkey)
  • 日本語 (Japan)
  • Russian (Russia)
  • Français (France)
  • Deutsch (Deutschland)
  • Español (España)
  • Nederlands (nl-NL)
  • Português Brasileiro (pt-BR)
  • Polski (PL)
  • Italiano (Italia)
  • English (United Kingdom)

Tweets by A_Tinfo

  • Sitemap
Ataxia Telangiectasia
  • Home
  • Bibliography
    • Authors
    • Cells and molecules
    • Clinical
    • Country
    • Diseases
    • Drugs
    • Experimental
    • Journals
    • Methods
    • Year
  • Resources
  • What is A-T?
  • News
  • admin@ataxiatelangiectasia.es